Metabolic syndrome common in people with psychotic disorders, particularly in users of high potency antipsychotics

被引：0
|
作者：
Suivisaari, Jaana [1 ]
机构：
[1] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Mannerheimintie 166, FIN-00300 Helsinki, Finland
来源：
EVIDENCE-BASED MENTAL HEALTH | 2008年 / 11卷 / 02期
基金：
芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [41] High burden of the metabolic syndrome and its component disorders in South Africans with psoriasis
    Mahyoodeen, Nasrin Goolam
    Crowther, Nigel J.
    Snyman, Tracy
    Pillay, Lushen
    Tikly, Mohammed
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (05) : 557 - 562
  • [42] Coproducing healthcare service improvement for people with common mental health disorders including psychotic experiences: a study protocol of a multiperspective qualitative study
    Georgiadis, Alexandros
    Duschinsky, Robbie
    Perez, Jesus
    Jones, Peter B.
    Russo, Debra
    Knight, Clare
    Soneson, Emma
    Dixon-Woods, Mary
    BMJ OPEN, 2018, 8 (11):
  • [43] Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders
    Penas-Steinhardt, Alberto
    Tellechea, Mariana L.
    Gomez-Rosso, Leonardo
    Brites, Fernando
    Frechtel, Gustavo D.
    Poskus, Edgardo
    BMC MEDICAL GENETICS, 2011, 12
  • [44] Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders
    Quintana, Daniel S.
    Dieset, Ingrid
    Elvsashagen, Torbjorn
    Westlye, Lars T.
    Andreassen, Ole A.
    FRONTIERS IN NEUROENDOCRINOLOGY, 2017, 45 : 1 - 10
  • [45] Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment
    De Filippis, Anna
    Ullah, Hammad
    Baldi, Alessandra
    Dacrema, Marco
    Esposito, Cristina
    Garzarella, Emanuele Ugo
    Santarcangelo, Cristina
    Tantipongpiradet, Ariyawan
    Daglia, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) : 1 - 26
  • [46] Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial
    Gardner-Sood, P.
    Lally, J.
    Smith, S.
    Atakan, Z.
    Ismail, K.
    Greenwood, K. E.
    Keen, A.
    O'Brien, C.
    Onagbesan, O.
    Fung, C.
    Papanastasiou, E.
    Eberherd, J.
    Patel, A.
    Ohlsen, R.
    Stahl, D.
    David, A.
    Hopkins, D.
    Murray, R. M.
    Gaughran, F.
    PSYCHOLOGICAL MEDICINE, 2015, 45 (12) : 2619 - 2629
  • [47] Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
    Sneller, Marius H.
    de Boer, Nini
    Everaars, Sophie
    Schuurmans, Max
    Guloksuz, Sinan
    Cahn, Wiepke
    Luykx, Jurjen J.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [48] Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: Data from the Australian Survey of High Impact Psychosis
    Suetani, Shuichi
    Saha, Sukanta
    Eyles, Darryl W.
    Scott, James G.
    McGrath, John J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 (09): : 921 - 929
  • [49] Chitosan modifies glycemic levels in people with metabolic syndrome and related disorders: meta-analysis with trial sequential analysis
    Wenfang Guo
    Letai Yi
    Baochang Zhou
    Minhui Li
    Nutrition Journal, 19
  • [50] Chitosan modifies glycemic levels in people with metabolic syndrome and related disorders: meta-analysis with trial sequential analysis
    Guo, Wenfang
    Yi, Letai
    Zhou, Baochang
    Li, Minhui
    NUTRITION JOURNAL, 2020, 19 (01)
12345